VYTRUS BIOTECH EO -01 Capital Reinvestment Ratio
VYTRUS BIOTECH EO -01 capital reinvestment ratio. VYTRUS BIOTECH EO -01 (V5P) has a Capital Reinvestment Ratio of 0.69x as of December 2025, meaning it reinvests 1% of its operating cash flow (€3.90 Million) in capital expenditures (€2.68 Million). Check total reinvestment intensity of VYTRUS BIOTECH EO -01 to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of VYTRUS BIOTECH EO -01 (2021–2025)
Capital reinvestment ratio of VYTRUS BIOTECH EO -01 from 2021 to 2025. This chart tracks VYTRUS BIOTECH EO -01's Capital Reinvestment Ratio across 5 annual periods. Also explore net asset growth rate of VYTRUS BIOTECH EO -01 to track the company's year-over-year net asset growth rate.
VYTRUS BIOTECH EO -01 Capital Reinvestment Ratio by Year (2021–2025)
VYTRUS BIOTECH EO -01 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see cash flow conversion of VYTRUS BIOTECH EO -01.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | €3.90 Million | €2.68 Million | ▲ +5.2% |
| 2024 | 0.65x | €1.84 Million | €1.20 Million | ▼ -49.4% |
| 2023 | 1.29x | €904.39K | €1.17 Million | ▲ +2.2% |
| 2022 | 1.26x | €1.03 Million | €1.29 Million | ▲ +107.9% |
| 2021 | 0.61x | €447.92K | €271.82K | — |